113 related articles for article (PubMed ID: 11781835)
1. The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells.
Li C; Ahlborn TE; Tokita K; Boxer LM; Noda A; Liu J
Oncogene; 2001 Dec; 20(57):8193-202. PubMed ID: 11781835
[TBL] [Abstract][Full Text] [Related]
2. The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M.
Liu J; Li C; Ahlborn TE; Spence MJ; Meng L; Boxer LM
Cell Growth Differ; 1999 Oct; 10(10):677-83. PubMed ID: 10547071
[TBL] [Abstract][Full Text] [Related]
3. A unique, short sequence determines p53 gene basal and UV-inducible expression in normal human cells.
Noda A; Toma-Aiba Y; Fujiwara Y
Oncogene; 2000 Jan; 19(1):21-31. PubMed ID: 10644976
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
5. Oncostatin M-mediated transcriptional suppression of the c-myc gene in breast cancer cells.
Spence MJ; Vestal RE; Liu J
Cancer Res; 1997 Jun; 57(11):2223-8. PubMed ID: 9187125
[TBL] [Abstract][Full Text] [Related]
6. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.
Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J
Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
8. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
9. Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells.
Zhang F; Li C; Halfter H; Liu J
Oncogene; 2003 Feb; 22(6):894-905. PubMed ID: 12584569
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of transcriptional repression of gelsolin in human breast cancer cells.
Dong Y; Asch HL; Ying A; Asch BB
Exp Cell Res; 2002 Jun; 276(2):328-36. PubMed ID: 12027462
[TBL] [Abstract][Full Text] [Related]
12. Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene.
Wei X; Xu H; Kufe D
Cancer Res; 2007 Feb; 67(4):1853-8. PubMed ID: 17308127
[TBL] [Abstract][Full Text] [Related]
13. Induction of Egr-1 by oncostatin M precedes up-regulation of low density lipoprotein receptors in HepG2 cells.
Liu J; Shoyab M; Grove RI
Cell Growth Differ; 1993 Jul; 4(7):611-6. PubMed ID: 8398902
[TBL] [Abstract][Full Text] [Related]
14. Cell type-specific bidirectional regulation of the glucocorticoid-induced leucine zipper (GILZ) gene by estrogen.
Tynan SH; Lundeen SG; Allan GF
J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):225-39. PubMed ID: 15336700
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a cAMP-responsive element in the region upstream from promoter 1.3 of the human aromatase gene.
Zhou D; Chen S
Arch Biochem Biophys; 1999 Nov; 371(2):179-90. PubMed ID: 10545204
[TBL] [Abstract][Full Text] [Related]
16. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
Hsiang CH; Straus DS
Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
[TBL] [Abstract][Full Text] [Related]
17. The UV responsive elements in the human mimecan promoter: a functional characterization.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jan; 9():1-9. PubMed ID: 12533723
[TBL] [Abstract][Full Text] [Related]
18. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
[TBL] [Abstract][Full Text] [Related]
19. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
20. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes.
Huang YH; Wu JY; Zhang Y; Wu MX
Oncogene; 2002 Oct; 21(44):6819-28. PubMed ID: 12360408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
